Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Waldenstrom Macroglobulinemia | 247 | 2024 | 1073 | 42.480 |
Why?
|
Myeloid Differentiation Factor 88 | 70 | 2024 | 586 | 13.250 |
Why?
|
Receptors, CXCR4 | 38 | 2024 | 727 | 7.940 |
Why?
|
Adenine | 58 | 2024 | 986 | 7.650 |
Why?
|
Pyrazoles | 47 | 2024 | 2007 | 6.740 |
Why?
|
Piperidines | 60 | 2024 | 1656 | 6.390 |
Why?
|
Pyrimidines | 50 | 2024 | 3024 | 6.020 |
Why?
|
Immunoglobulin M | 64 | 2023 | 1530 | 5.560 |
Why?
|
Protein Kinase Inhibitors | 32 | 2024 | 5662 | 2.950 |
Why?
|
Antineoplastic Agents | 55 | 2023 | 13616 | 2.600 |
Why?
|
Mutation | 59 | 2024 | 30025 | 2.440 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 36 | 2015 | 694 | 2.390 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 38 | 2021 | 11729 | 2.150 |
Why?
|
Lymphoma, B-Cell | 12 | 2023 | 940 | 1.960 |
Why?
|
Proto-Oncogene Proteins c-hck | 6 | 2024 | 46 | 1.920 |
Why?
|
Antibodies, Monoclonal | 45 | 2021 | 9176 | 1.910 |
Why?
|
Blood Viscosity | 8 | 2019 | 124 | 1.550 |
Why?
|
Boronic Acids | 21 | 2015 | 914 | 1.550 |
Why?
|
Bone Marrow | 22 | 2021 | 2907 | 1.550 |
Why?
|
Pyrazines | 23 | 2021 | 1199 | 1.520 |
Why?
|
B-Lymphocytes | 26 | 2022 | 4748 | 1.500 |
Why?
|
Neoplasm Proteins | 11 | 2021 | 3610 | 1.460 |
Why?
|
Multiple Myeloma | 61 | 2024 | 5143 | 1.410 |
Why?
|
Receptors, IgG | 6 | 2011 | 559 | 1.280 |
Why?
|
Apoptosis | 35 | 2024 | 9468 | 1.210 |
Why?
|
Drug Resistance, Neoplasm | 12 | 2024 | 5292 | 1.190 |
Why?
|
Humans | 331 | 2024 | 760437 | 1.050 |
Why?
|
Antigens, CD20 | 11 | 2019 | 201 | 1.040 |
Why?
|
Quinazolinones | 3 | 2016 | 221 | 1.020 |
Why?
|
Protein-Tyrosine Kinases | 16 | 2017 | 2423 | 1.020 |
Why?
|
Signal Transduction | 41 | 2024 | 23397 | 0.970 |
Why?
|
Plasma Cells | 9 | 2022 | 599 | 0.960 |
Why?
|
Purines | 4 | 2016 | 605 | 0.950 |
Why?
|
Aged | 99 | 2024 | 168840 | 0.940 |
Why?
|
Antibodies, Neoplasm | 6 | 2011 | 281 | 0.930 |
Why?
|
Disease-Free Survival | 20 | 2019 | 6813 | 0.930 |
Why?
|
Aged, 80 and over | 56 | 2024 | 58859 | 0.900 |
Why?
|
Plasmapheresis | 6 | 2017 | 206 | 0.870 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 3 | 2015 | 179 | 0.860 |
Why?
|
Middle Aged | 105 | 2024 | 220382 | 0.850 |
Why?
|
Lymphoproliferative Disorders | 4 | 2016 | 533 | 0.830 |
Why?
|
Paraproteinemias | 10 | 2017 | 248 | 0.820 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 4 | 2014 | 614 | 0.780 |
Why?
|
Sulfonamides | 4 | 2024 | 1973 | 0.770 |
Why?
|
Lymphoma, Non-Hodgkin | 6 | 2015 | 1373 | 0.760 |
Why?
|
Vidarabine | 6 | 2015 | 336 | 0.740 |
Why?
|
Lymphoma | 6 | 2022 | 1901 | 0.720 |
Why?
|
Antigens, CD | 12 | 2011 | 4000 | 0.710 |
Why?
|
Survival Rate | 18 | 2021 | 12698 | 0.700 |
Why?
|
Immunization, Passive | 7 | 2005 | 616 | 0.700 |
Why?
|
Thalidomide | 11 | 2013 | 885 | 0.700 |
Why?
|
Mutation, Missense | 3 | 2019 | 2571 | 0.700 |
Why?
|
Male | 117 | 2024 | 360035 | 0.670 |
Why?
|
Histone Deacetylase Inhibitors | 5 | 2020 | 774 | 0.670 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2019 | 2821 | 0.640 |
Why?
|
Dexamethasone | 17 | 2023 | 1944 | 0.640 |
Why?
|
Female | 110 | 2024 | 391875 | 0.620 |
Why?
|
Amino Acid Substitution | 7 | 2019 | 1737 | 0.620 |
Why?
|
Genomics | 9 | 2024 | 5806 | 0.620 |
Why?
|
Neoplasms, Second Primary | 3 | 2015 | 1051 | 0.610 |
Why?
|
Tumor Cells, Cultured | 39 | 2021 | 6128 | 0.600 |
Why?
|
Retinal Diseases | 3 | 2009 | 704 | 0.580 |
Why?
|
Cell Proliferation | 16 | 2024 | 10425 | 0.570 |
Why?
|
Treatment Outcome | 45 | 2024 | 64591 | 0.560 |
Why?
|
Point Mutation | 3 | 2021 | 1595 | 0.550 |
Why?
|
Sirolimus | 5 | 2015 | 1533 | 0.550 |
Why?
|
Adult | 67 | 2024 | 220781 | 0.530 |
Why?
|
Cell Survival | 21 | 2024 | 5790 | 0.530 |
Why?
|
Nucleosides | 4 | 2010 | 131 | 0.530 |
Why?
|
SEER Program | 4 | 2017 | 1449 | 0.520 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 4 | 2021 | 1405 | 0.510 |
Why?
|
Cyclophosphamide | 9 | 2023 | 2218 | 0.510 |
Why?
|
Lung Injury | 1 | 2020 | 422 | 0.500 |
Why?
|
Molecular Targeted Therapy | 7 | 2020 | 2805 | 0.500 |
Why?
|
Kaplan-Meier Estimate | 10 | 2020 | 6471 | 0.490 |
Why?
|
Bone Marrow Cells | 10 | 2011 | 2416 | 0.470 |
Why?
|
Immunoglobulin G | 6 | 2016 | 4549 | 0.460 |
Why?
|
Alkylating Agents | 5 | 2017 | 133 | 0.460 |
Why?
|
von Willebrand Factor | 1 | 2018 | 673 | 0.460 |
Why?
|
Drug Tolerance | 1 | 2015 | 367 | 0.450 |
Why?
|
Apoptosis Regulatory Proteins | 6 | 2015 | 1135 | 0.450 |
Why?
|
Warts | 1 | 2013 | 66 | 0.440 |
Why?
|
Prognosis | 27 | 2024 | 29551 | 0.440 |
Why?
|
Glycoproteins | 4 | 2011 | 2207 | 0.440 |
Why?
|
Withholding Treatment | 1 | 2018 | 617 | 0.440 |
Why?
|
Antigens, Neoplasm | 4 | 2011 | 1994 | 0.440 |
Why?
|
Codon, Nonsense | 1 | 2014 | 285 | 0.430 |
Why?
|
Mice, SCID | 15 | 2021 | 2625 | 0.430 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 4 | 2021 | 1404 | 0.430 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2018 | 625 | 0.430 |
Why?
|
Hydroxamic Acids | 4 | 2013 | 481 | 0.420 |
Why?
|
Follow-Up Studies | 16 | 2021 | 39078 | 0.420 |
Why?
|
Tumor Necrosis Factor-alpha | 10 | 2002 | 4355 | 0.420 |
Why?
|
Survival Analysis | 14 | 2020 | 10075 | 0.420 |
Why?
|
Frameshift Mutation | 1 | 2014 | 392 | 0.420 |
Why?
|
Paraproteins | 4 | 2020 | 38 | 0.410 |
Why?
|
Peripheral Nervous System Diseases | 6 | 2017 | 710 | 0.410 |
Why?
|
Disease Progression | 20 | 2021 | 13484 | 0.410 |
Why?
|
Cell Line, Tumor | 24 | 2024 | 16945 | 0.410 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 3 | 2018 | 76 | 0.400 |
Why?
|
Mast Cells | 4 | 2008 | 1391 | 0.400 |
Why?
|
Proto-Oncogene Proteins | 10 | 2015 | 4509 | 0.390 |
Why?
|
NF-kappa B | 13 | 2020 | 2485 | 0.390 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2022 | 3631 | 0.390 |
Why?
|
Proto-Oncogene Proteins c-akt | 8 | 2018 | 2453 | 0.380 |
Why?
|
Salvage Therapy | 7 | 2018 | 1264 | 0.380 |
Why?
|
Polymorphism, Genetic | 5 | 2011 | 4287 | 0.370 |
Why?
|
Matrix Metalloproteinase 8 | 1 | 2011 | 56 | 0.370 |
Why?
|
Antigens, CD19 | 4 | 2024 | 425 | 0.370 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 4 | 2007 | 303 | 0.370 |
Why?
|
Nitrogen Mustard Compounds | 4 | 2015 | 44 | 0.370 |
Why?
|
Polymerase Chain Reaction | 6 | 2015 | 6086 | 0.360 |
Why?
|
Central Nervous System Neoplasms | 2 | 2016 | 916 | 0.360 |
Why?
|
Anemia | 3 | 2011 | 1508 | 0.360 |
Why?
|
Gene Expression Regulation, Neoplastic | 18 | 2018 | 8519 | 0.350 |
Why?
|
Immunologic Factors | 5 | 2014 | 1588 | 0.350 |
Why?
|
Membrane Glycoproteins | 11 | 2016 | 3701 | 0.340 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2013 | 557 | 0.340 |
Why?
|
Vincristine | 4 | 2021 | 1036 | 0.330 |
Why?
|
Lymphoma, Mantle-Cell | 2 | 2024 | 237 | 0.320 |
Why?
|
Syndrome | 4 | 2018 | 3267 | 0.320 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 3 | 2011 | 687 | 0.320 |
Why?
|
Tunicamycin | 1 | 2008 | 108 | 0.320 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2013 | 369 | 0.310 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2011 | 353 | 0.310 |
Why?
|
Lymphocytes | 3 | 2013 | 2610 | 0.310 |
Why?
|
Prospective Studies | 12 | 2023 | 54339 | 0.300 |
Why?
|
Hypergammaglobulinemia | 1 | 2008 | 72 | 0.300 |
Why?
|
Gene Expression Profiling | 13 | 2018 | 9410 | 0.300 |
Why?
|
Agammaglobulinemia | 1 | 2009 | 173 | 0.300 |
Why?
|
Recurrence | 13 | 2015 | 8466 | 0.300 |
Why?
|
Genes, Regulator | 1 | 2009 | 374 | 0.300 |
Why?
|
Interleukin-6 | 15 | 2016 | 3209 | 0.300 |
Why?
|
Boron Compounds | 2 | 2020 | 182 | 0.300 |
Why?
|
Consensus | 8 | 2023 | 3115 | 0.290 |
Why?
|
Flow Cytometry | 13 | 2013 | 5865 | 0.290 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 2 | 2018 | 83 | 0.280 |
Why?
|
Prednisone | 4 | 2021 | 1564 | 0.280 |
Why?
|
Doxorubicin | 6 | 2021 | 2215 | 0.280 |
Why?
|
Stilbenes | 1 | 2008 | 155 | 0.280 |
Why?
|
Immunoglobulin A | 3 | 2009 | 980 | 0.280 |
Why?
|
Mucin-1 | 3 | 2001 | 539 | 0.280 |
Why?
|
Gene Expression | 9 | 2019 | 7582 | 0.280 |
Why?
|
Hepatitis C Antibodies | 1 | 2007 | 146 | 0.270 |
Why?
|
Family Health | 1 | 2011 | 1257 | 0.270 |
Why?
|
Enzyme Inhibitors | 7 | 2011 | 3710 | 0.270 |
Why?
|
Stress, Physiological | 2 | 2011 | 1400 | 0.270 |
Why?
|
CD40 Ligand | 4 | 2006 | 526 | 0.270 |
Why?
|
Gene Deletion | 2 | 2013 | 2667 | 0.270 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2020 | 373 | 0.260 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2018 | 2058 | 0.260 |
Why?
|
Glycine | 2 | 2020 | 665 | 0.260 |
Why?
|
Enzyme Activation | 11 | 2022 | 3592 | 0.260 |
Why?
|
Simvastatin | 1 | 2008 | 346 | 0.260 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2022 | 5663 | 0.250 |
Why?
|
Cell Adhesion | 7 | 2024 | 3088 | 0.250 |
Why?
|
Leukemia, Myeloid, Acute | 6 | 2009 | 3610 | 0.240 |
Why?
|
Immunophenotyping | 9 | 2019 | 1870 | 0.240 |
Why?
|
Biomedical Research | 2 | 2018 | 3421 | 0.240 |
Why?
|
Sp1 Transcription Factor | 2 | 2016 | 140 | 0.240 |
Why?
|
MAP Kinase Signaling System | 2 | 2024 | 1485 | 0.230 |
Why?
|
Iron | 1 | 2013 | 1787 | 0.230 |
Why?
|
Receptors, Antigen, B-Cell | 3 | 2016 | 545 | 0.230 |
Why?
|
Protease Inhibitors | 2 | 2007 | 753 | 0.230 |
Why?
|
Endoplasmic Reticulum | 2 | 2018 | 1133 | 0.230 |
Why?
|
Chromosome Deletion | 2 | 2020 | 1387 | 0.230 |
Why?
|
Retinal Vessels | 2 | 2008 | 851 | 0.230 |
Why?
|
beta 2-Microglobulin | 4 | 2020 | 329 | 0.230 |
Why?
|
Mastocytosis | 1 | 2006 | 149 | 0.230 |
Why?
|
Drug Administration Schedule | 5 | 2011 | 4849 | 0.220 |
Why?
|
MicroRNAs | 6 | 2018 | 3796 | 0.220 |
Why?
|
Mice, Inbred NOD | 5 | 2021 | 1824 | 0.220 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2005 | 263 | 0.220 |
Why?
|
Stem Cell Transplantation | 5 | 2017 | 1598 | 0.220 |
Why?
|
Receptors, IgE | 1 | 2005 | 373 | 0.220 |
Why?
|
Membrane Proteins | 3 | 2016 | 7849 | 0.220 |
Why?
|
Killer Cells, Natural | 4 | 2007 | 2202 | 0.210 |
Why?
|
Hematocrit | 3 | 2011 | 625 | 0.210 |
Why?
|
Leucine | 2 | 2016 | 548 | 0.210 |
Why?
|
DNA-Binding Proteins | 8 | 2014 | 9598 | 0.210 |
Why?
|
Lipopolysaccharides | 5 | 1994 | 2205 | 0.210 |
Why?
|
Transplantation, Heterologous | 7 | 2007 | 2385 | 0.210 |
Why?
|
Clinical Trials as Topic | 7 | 2020 | 7996 | 0.210 |
Why?
|
Proline | 2 | 2016 | 457 | 0.210 |
Why?
|
Epigenomics | 2 | 2020 | 940 | 0.210 |
Why?
|
Cladribine | 2 | 2015 | 34 | 0.210 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2015 | 2204 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3080 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3200 | 0.200 |
Why?
|
Hemoglobins | 5 | 2018 | 1524 | 0.200 |
Why?
|
Neprilysin | 1 | 2005 | 474 | 0.200 |
Why?
|
Amyloidosis | 3 | 2004 | 817 | 0.200 |
Why?
|
Interferon-gamma | 6 | 2002 | 3157 | 0.200 |
Why?
|
Myelodysplastic Syndromes | 2 | 2008 | 1393 | 0.190 |
Why?
|
Cyanosis | 1 | 2021 | 86 | 0.190 |
Why?
|
Genetic Linkage | 1 | 2007 | 2382 | 0.190 |
Why?
|
Immunotherapy | 7 | 2017 | 4649 | 0.190 |
Why?
|
Immunoblotting | 4 | 2012 | 1647 | 0.190 |
Why?
|
Epigenesis, Genetic | 3 | 2020 | 3782 | 0.190 |
Why?
|
Leukemia, Promyelocytic, Acute | 2 | 1994 | 251 | 0.190 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2021 | 169 | 0.180 |
Why?
|
Caspase 1 | 1 | 2022 | 226 | 0.180 |
Why?
|
Oligopeptides | 3 | 2015 | 1186 | 0.180 |
Why?
|
DNA Copy Number Variations | 3 | 2021 | 2017 | 0.180 |
Why?
|
Immunotherapy, Active | 1 | 2000 | 59 | 0.180 |
Why?
|
Algorithms | 3 | 2017 | 14002 | 0.180 |
Why?
|
Transcription Factors | 7 | 2015 | 12121 | 0.180 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2023 | 150 | 0.180 |
Why?
|
Retrospective Studies | 19 | 2024 | 80430 | 0.180 |
Why?
|
Transplantation, Autologous | 3 | 2022 | 2113 | 0.180 |
Why?
|
Proportional Hazards Models | 4 | 2021 | 12429 | 0.180 |
Why?
|
Cell Line | 5 | 2018 | 15598 | 0.180 |
Why?
|
Vasodilator Agents | 1 | 2004 | 973 | 0.180 |
Why?
|
Phenotype | 4 | 2016 | 16585 | 0.170 |
Why?
|
Incidence | 8 | 2018 | 21322 | 0.170 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2021 | 147 | 0.170 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2020 | 617 | 0.170 |
Why?
|
Neoplasms | 5 | 2022 | 22083 | 0.170 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2012 | 4567 | 0.170 |
Why?
|
Histone Deacetylases | 3 | 2020 | 719 | 0.170 |
Why?
|
Hepacivirus | 1 | 2007 | 1337 | 0.170 |
Why?
|
Genotype | 5 | 2017 | 12976 | 0.170 |
Why?
|
Transcriptional Activation | 3 | 2016 | 1753 | 0.170 |
Why?
|
Acrylamides | 2 | 2018 | 259 | 0.170 |
Why?
|
Integrins | 1 | 2024 | 834 | 0.170 |
Why?
|
Adaptor Proteins, Signal Transducing | 6 | 2022 | 2895 | 0.170 |
Why?
|
Drug Synergism | 6 | 2018 | 1755 | 0.160 |
Why?
|
Disease Management | 3 | 2020 | 2501 | 0.160 |
Why?
|
DNA Mutational Analysis | 3 | 2021 | 4108 | 0.160 |
Why?
|
Case-Control Studies | 7 | 2020 | 22097 | 0.160 |
Why?
|
Databases, Factual | 1 | 2014 | 7948 | 0.160 |
Why?
|
Models, Biological | 2 | 2014 | 9462 | 0.160 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2015 | 2870 | 0.160 |
Why?
|
Portraits as Topic | 1 | 2018 | 32 | 0.160 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 5 | 2002 | 192 | 0.160 |
Why?
|
Registries | 1 | 2014 | 8216 | 0.160 |
Why?
|
Diagnosis, Differential | 4 | 2017 | 12969 | 0.150 |
Why?
|
Animals | 36 | 2022 | 168253 | 0.150 |
Why?
|
RNA, Viral | 1 | 2007 | 2846 | 0.150 |
Why?
|
Blood Proteins | 2 | 2016 | 1174 | 0.150 |
Why?
|
Cytokines | 7 | 2018 | 7377 | 0.150 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2020 | 452 | 0.150 |
Why?
|
Neutropenia | 3 | 2009 | 884 | 0.150 |
Why?
|
Estrogen Antagonists | 1 | 1998 | 150 | 0.150 |
Why?
|
Brain Neoplasms | 1 | 2019 | 9003 | 0.150 |
Why?
|
Sequence Analysis, DNA | 4 | 2015 | 4735 | 0.150 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2023 | 2509 | 0.150 |
Why?
|
p21-Activated Kinases | 1 | 2018 | 128 | 0.150 |
Why?
|
Immunoglobulin Light Chains | 3 | 2012 | 286 | 0.150 |
Why?
|
Cells, Cultured | 8 | 2013 | 18955 | 0.140 |
Why?
|
Chemokine CXCL13 | 1 | 2017 | 59 | 0.140 |
Why?
|
Patient Care | 1 | 2023 | 621 | 0.140 |
Why?
|
Benzamides | 2 | 2021 | 1370 | 0.140 |
Why?
|
Ophthalmoscopy | 2 | 2009 | 171 | 0.140 |
Why?
|
DNA Methylation | 5 | 2020 | 4383 | 0.140 |
Why?
|
Time Factors | 11 | 2021 | 39947 | 0.140 |
Why?
|
Aminopyridines | 2 | 2018 | 570 | 0.140 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2018 | 242 | 0.140 |
Why?
|
Protein Multimerization | 3 | 2017 | 982 | 0.140 |
Why?
|
Laser-Doppler Flowmetry | 2 | 2008 | 239 | 0.140 |
Why?
|
Plasma | 1 | 2020 | 585 | 0.140 |
Why?
|
Immunotherapy, Adoptive | 2 | 2024 | 1463 | 0.140 |
Why?
|
Phosphorylation | 13 | 2016 | 8311 | 0.140 |
Why?
|
Lymph Nodes | 2 | 2021 | 3469 | 0.140 |
Why?
|
Mice | 26 | 2022 | 81402 | 0.140 |
Why?
|
Cell Adhesion Molecules | 1 | 2003 | 1600 | 0.140 |
Why?
|
Pathology, Molecular | 1 | 2020 | 328 | 0.140 |
Why?
|
Inflammasomes | 1 | 2022 | 523 | 0.140 |
Why?
|
Fatal Outcome | 1 | 2021 | 1832 | 0.140 |
Why?
|
Caspases | 4 | 2011 | 876 | 0.140 |
Why?
|
Drug Eruptions | 1 | 2019 | 335 | 0.140 |
Why?
|
Antimetabolites | 2 | 2014 | 128 | 0.140 |
Why?
|
Hepatitis C | 1 | 2007 | 1583 | 0.130 |
Why?
|
Glucuronosyltransferase | 2 | 2008 | 131 | 0.130 |
Why?
|
Biopsy | 5 | 2019 | 6765 | 0.130 |
Why?
|
Paracrine Communication | 1 | 2018 | 276 | 0.130 |
Why?
|
von Willebrand Diseases | 1 | 2018 | 132 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 8 | 2019 | 17854 | 0.130 |
Why?
|
Chromosome Aberrations | 4 | 2014 | 1771 | 0.130 |
Why?
|
Chemokine CXCL12 | 2 | 2015 | 454 | 0.130 |
Why?
|
Practice Guidelines as Topic | 9 | 2020 | 7380 | 0.130 |
Why?
|
Magnetic Resonance Imaging | 5 | 2019 | 36362 | 0.130 |
Why?
|
Hematology | 1 | 2019 | 244 | 0.130 |
Why?
|
Cell Division | 10 | 2000 | 4461 | 0.130 |
Why?
|
Alleles | 3 | 2019 | 6908 | 0.130 |
Why?
|
Drug Therapy, Combination | 3 | 2015 | 6297 | 0.130 |
Why?
|
Glucocorticoids | 3 | 2003 | 2163 | 0.130 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5815 | 0.130 |
Why?
|
Pleural Effusion, Malignant | 1 | 2016 | 106 | 0.130 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6894 | 0.120 |
Why?
|
Histocytochemistry | 1 | 2016 | 698 | 0.120 |
Why?
|
Cyclophilin A | 1 | 2015 | 58 | 0.120 |
Why?
|
Exanthema | 1 | 2019 | 504 | 0.120 |
Why?
|
Disease Models, Animal | 5 | 2019 | 18216 | 0.120 |
Why?
|
Liver Function Tests | 1 | 2016 | 522 | 0.120 |
Why?
|
Octamer Transcription Factor-2 | 1 | 2014 | 7 | 0.120 |
Why?
|
Herpesvirus 8, Human | 4 | 2000 | 255 | 0.120 |
Why?
|
Autoantibodies | 2 | 2000 | 2123 | 0.120 |
Why?
|
Inhibitor of Differentiation Protein 2 | 1 | 2014 | 30 | 0.120 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2015 | 178 | 0.120 |
Why?
|
Mutant Proteins | 1 | 2016 | 491 | 0.120 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2017 | 2860 | 0.110 |
Why?
|
Piperazines | 1 | 2004 | 2519 | 0.110 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2017 | 495 | 0.110 |
Why?
|
Toll-Like Receptors | 1 | 2017 | 589 | 0.110 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2014 | 168 | 0.110 |
Why?
|
Periodicals as Topic | 2 | 2018 | 1463 | 0.110 |
Why?
|
Protein Binding | 4 | 2017 | 9340 | 0.110 |
Why?
|
Blood Protein Electrophoresis | 1 | 2013 | 71 | 0.110 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 4 | 1999 | 489 | 0.110 |
Why?
|
Blood Flow Velocity | 2 | 2008 | 1370 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2021 | 10759 | 0.110 |
Why?
|
Combined Modality Therapy | 4 | 2016 | 8522 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2018 | 3590 | 0.110 |
Why?
|
Translocation, Genetic | 2 | 2021 | 1388 | 0.110 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 732 | 0.110 |
Why?
|
Reye Syndrome | 1 | 1992 | 28 | 0.110 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 3243 | 0.110 |
Why?
|
Hematologic Neoplasms | 2 | 2022 | 1890 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinases | 6 | 2004 | 1246 | 0.110 |
Why?
|
Medical Oncology | 2 | 2017 | 2318 | 0.110 |
Why?
|
Molecular Sequence Data | 5 | 2013 | 17639 | 0.100 |
Why?
|
Oxazines | 1 | 2015 | 348 | 0.100 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 1996 | 643 | 0.100 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2016 | 651 | 0.100 |
Why?
|
Kupffer Cells | 1 | 1993 | 143 | 0.100 |
Why?
|
Remission Induction | 3 | 2014 | 2394 | 0.100 |
Why?
|
Adjuvants, Immunologic | 3 | 2003 | 1035 | 0.100 |
Why?
|
Gene Knockdown Techniques | 2 | 2014 | 1610 | 0.100 |
Why?
|
Immunoglobulins | 2 | 2017 | 859 | 0.100 |
Why?
|
Comparative Genomic Hybridization | 1 | 2013 | 473 | 0.100 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 1994 | 282 | 0.100 |
Why?
|
Prostatic Neoplasms | 1 | 2015 | 11095 | 0.100 |
Why?
|
Drug Resistance | 2 | 2019 | 1597 | 0.100 |
Why?
|
Quality of Life | 3 | 2024 | 13338 | 0.100 |
Why?
|
Leukemia, Myelomonocytic, Acute | 1 | 1992 | 38 | 0.100 |
Why?
|
Cell Cycle | 4 | 2015 | 2929 | 0.100 |
Why?
|
Electrophoresis, Capillary | 2 | 2009 | 63 | 0.100 |
Why?
|
Stem Cells | 1 | 2005 | 3522 | 0.100 |
Why?
|
Transferrin | 1 | 2013 | 284 | 0.100 |
Why?
|
Sjogren's Syndrome | 1 | 2013 | 234 | 0.100 |
Why?
|
Cell Communication | 2 | 2018 | 1652 | 0.100 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2012 | 85 | 0.100 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2016 | 611 | 0.100 |
Why?
|
Luciferases | 1 | 2013 | 714 | 0.100 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2018 | 2911 | 0.100 |
Why?
|
Genomic Instability | 1 | 2015 | 709 | 0.100 |
Why?
|
Proteomics | 4 | 2017 | 3818 | 0.100 |
Why?
|
Receptors, Cell Surface | 1 | 2020 | 2819 | 0.090 |
Why?
|
Lymphoma, Follicular | 1 | 2015 | 457 | 0.090 |
Why?
|
Stomatitis | 1 | 2014 | 271 | 0.090 |
Why?
|
Cell Movement | 6 | 2015 | 5198 | 0.090 |
Why?
|
Base Sequence | 5 | 2016 | 12449 | 0.090 |
Why?
|
Immunoprecipitation | 1 | 2013 | 877 | 0.090 |
Why?
|
Thrombocytopenia | 2 | 2009 | 1174 | 0.090 |
Why?
|
Diagnostic Tests, Routine | 1 | 2016 | 786 | 0.090 |
Why?
|
Lung Neoplasms | 1 | 2015 | 13312 | 0.090 |
Why?
|
Hepatitis | 1 | 1992 | 229 | 0.090 |
Why?
|
Lentivirus | 1 | 2013 | 508 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2016 | 988 | 0.090 |
Why?
|
Nuclear Proteins | 5 | 2013 | 5794 | 0.090 |
Why?
|
Blood Cell Count | 1 | 2011 | 397 | 0.090 |
Why?
|
Ubiquitins | 1 | 2012 | 366 | 0.090 |
Why?
|
Immunosuppressive Agents | 4 | 2012 | 4168 | 0.090 |
Why?
|
Hematologic Diseases | 1 | 2014 | 496 | 0.090 |
Why?
|
Drug Evaluation | 1 | 2011 | 642 | 0.090 |
Why?
|
Blood-Brain Barrier | 1 | 2016 | 1024 | 0.080 |
Why?
|
Methotrexate | 1 | 1996 | 1720 | 0.080 |
Why?
|
Stromal Cells | 4 | 2012 | 1330 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2022 | 3059 | 0.080 |
Why?
|
Blotting, Western | 3 | 2013 | 5031 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2018 | 15867 | 0.080 |
Why?
|
DNA Repair | 1 | 2018 | 2044 | 0.080 |
Why?
|
Complementarity Determining Regions | 2 | 2007 | 149 | 0.080 |
Why?
|
Chlorambucil | 1 | 2008 | 42 | 0.080 |
Why?
|
United States | 5 | 2021 | 72202 | 0.080 |
Why?
|
Antigens, Nuclear | 2 | 2000 | 184 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2019 | 1998 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2014 | 3800 | 0.080 |
Why?
|
Breast Neoplasms | 2 | 2015 | 20985 | 0.080 |
Why?
|
Mice, Transgenic | 4 | 2019 | 9533 | 0.080 |
Why?
|
Asymptomatic Diseases | 3 | 2019 | 587 | 0.080 |
Why?
|
Coculture Techniques | 3 | 2012 | 1340 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2018 | 10180 | 0.080 |
Why?
|
Bone Marrow Neoplasms | 1 | 2009 | 101 | 0.080 |
Why?
|
Gene Expression Regulation | 5 | 2018 | 11900 | 0.080 |
Why?
|
Transfection | 5 | 2011 | 5776 | 0.080 |
Why?
|
Neoplasm Transplantation | 5 | 2014 | 2014 | 0.080 |
Why?
|
Down-Regulation | 6 | 2016 | 2911 | 0.080 |
Why?
|
Promoter Regions, Genetic | 2 | 2016 | 5778 | 0.070 |
Why?
|
Nerve Tissue Proteins | 1 | 2020 | 4413 | 0.070 |
Why?
|
beta Catenin | 2 | 2015 | 1040 | 0.070 |
Why?
|
Morbidity | 1 | 2013 | 1750 | 0.070 |
Why?
|
TCF Transcription Factors | 1 | 2008 | 138 | 0.070 |
Why?
|
Germ-Line Mutation | 1 | 2016 | 1850 | 0.070 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2011 | 632 | 0.070 |
Why?
|
Genes, p16 | 2 | 1997 | 159 | 0.070 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 2 | 2007 | 91 | 0.070 |
Why?
|
Cohort Studies | 3 | 2015 | 41366 | 0.070 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2007 | 57 | 0.070 |
Why?
|
Diarrhea | 1 | 2014 | 1319 | 0.070 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1739 | 0.070 |
Why?
|
Splenomegaly | 3 | 2003 | 189 | 0.070 |
Why?
|
Authorship | 1 | 2010 | 283 | 0.070 |
Why?
|
Trans-Activators | 3 | 2014 | 2858 | 0.070 |
Why?
|
Fatigue | 1 | 2014 | 1550 | 0.070 |
Why?
|
Herpes Zoster | 1 | 2009 | 253 | 0.070 |
Why?
|
Hemorrhage | 1 | 2018 | 3414 | 0.070 |
Why?
|
Cell Differentiation | 4 | 2014 | 11526 | 0.070 |
Why?
|
Tumor Burden | 2 | 2014 | 1887 | 0.070 |
Why?
|
Platelet Count | 1 | 2009 | 780 | 0.070 |
Why?
|
Catechin | 1 | 2006 | 69 | 0.070 |
Why?
|
RNA, Small Interfering | 2 | 2013 | 3428 | 0.070 |
Why?
|
Microtubules | 1 | 1992 | 1074 | 0.070 |
Why?
|
Lymphatic Diseases | 3 | 2003 | 320 | 0.060 |
Why?
|
Models, Genetic | 2 | 2014 | 3445 | 0.060 |
Why?
|
Genes, Immunoglobulin | 2 | 2004 | 285 | 0.060 |
Why?
|
Advisory Committees | 2 | 2022 | 783 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2016 | 2093 | 0.060 |
Why?
|
Interphase | 1 | 2005 | 228 | 0.060 |
Why?
|
Chromosome Mapping | 1 | 2013 | 4630 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 2 | 2014 | 2047 | 0.060 |
Why?
|
Viral Proteins | 3 | 2002 | 1803 | 0.060 |
Why?
|
Caspase 9 | 2 | 2002 | 185 | 0.060 |
Why?
|
Logistic Models | 1 | 2020 | 13240 | 0.060 |
Why?
|
Age Factors | 4 | 2018 | 18379 | 0.060 |
Why?
|
Caspase 8 | 2 | 2002 | 189 | 0.060 |
Why?
|
Conflict of Interest | 1 | 2010 | 554 | 0.060 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2008 | 1337 | 0.060 |
Why?
|
Cancer Vaccines | 2 | 2004 | 1050 | 0.060 |
Why?
|
HEK293 Cells | 3 | 2022 | 4277 | 0.060 |
Why?
|
Protein Folding | 1 | 2008 | 867 | 0.060 |
Why?
|
Retinoblastoma Protein | 2 | 1999 | 671 | 0.060 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2010 | 973 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 1997 | 696 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9267 | 0.060 |
Why?
|
Amino Acid Sequence | 3 | 2013 | 13445 | 0.060 |
Why?
|
Lymphoma, T-Cell | 1 | 2006 | 304 | 0.060 |
Why?
|
VDJ Recombinases | 1 | 2004 | 84 | 0.060 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2008 | 621 | 0.060 |
Why?
|
Up-Regulation | 6 | 2007 | 4116 | 0.060 |
Why?
|
DNA Helicases | 2 | 2000 | 851 | 0.060 |
Why?
|
Disclosure | 1 | 2010 | 748 | 0.060 |
Why?
|
Bone and Bones | 1 | 2014 | 2566 | 0.060 |
Why?
|
Interleukin-17 | 1 | 2010 | 907 | 0.060 |
Why?
|
Genetic Variation | 3 | 2016 | 6570 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2016 | 11096 | 0.060 |
Why?
|
Receptors, Interleukin-6 | 3 | 2004 | 225 | 0.060 |
Why?
|
Cluster Analysis | 1 | 2011 | 2711 | 0.060 |
Why?
|
Karyotyping | 1 | 2005 | 1171 | 0.060 |
Why?
|
Caspase 3 | 2 | 2016 | 729 | 0.060 |
Why?
|
Immunoglobulin delta-Chains | 1 | 2003 | 7 | 0.060 |
Why?
|
Immunoglobulin J-Chains | 1 | 2003 | 26 | 0.060 |
Why?
|
Leukemia, Myeloid | 1 | 2006 | 694 | 0.060 |
Why?
|
Cell Death | 3 | 2016 | 1664 | 0.060 |
Why?
|
International Classification of Diseases | 1 | 2009 | 892 | 0.050 |
Why?
|
Drug Industry | 1 | 2010 | 788 | 0.050 |
Why?
|
GPI-Linked Proteins | 1 | 2005 | 468 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2852 | 0.050 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2024 | 411 | 0.050 |
Why?
|
Pyridines | 1 | 2015 | 2868 | 0.050 |
Why?
|
Codon | 1 | 2005 | 602 | 0.050 |
Why?
|
Risk Factors | 9 | 2019 | 74055 | 0.050 |
Why?
|
Cryoglobulinemia | 1 | 2003 | 84 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2008 | 3777 | 0.050 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2003 | 317 | 0.050 |
Why?
|
CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2002 | 46 | 0.050 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2002 | 188 | 0.050 |
Why?
|
Neutralization Tests | 2 | 2001 | 728 | 0.050 |
Why?
|
Protein Kinase C | 1 | 2007 | 1202 | 0.050 |
Why?
|
Sulfones | 1 | 2004 | 447 | 0.050 |
Why?
|
Neoplasm, Residual | 2 | 2012 | 1008 | 0.050 |
Why?
|
Enzyme Precursors | 1 | 2002 | 174 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2015 | 4575 | 0.050 |
Why?
|
Receptors, Interferon | 1 | 2002 | 116 | 0.050 |
Why?
|
Health Surveys | 1 | 2011 | 4056 | 0.050 |
Why?
|
Poly(ADP-ribose) Polymerases | 3 | 2016 | 427 | 0.050 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2008 | 1355 | 0.050 |
Why?
|
Splenectomy | 1 | 2003 | 391 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 3 | 2006 | 3734 | 0.050 |
Why?
|
Macrophages | 2 | 1994 | 5764 | 0.050 |
Why?
|
Neoadjuvant Therapy | 2 | 2012 | 2821 | 0.050 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2002 | 196 | 0.050 |
Why?
|
Cyclins | 3 | 1999 | 594 | 0.050 |
Why?
|
Sex Factors | 1 | 2015 | 10538 | 0.050 |
Why?
|
Bone Marrow Transplantation | 2 | 2006 | 2693 | 0.050 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 2000 | 457 | 0.050 |
Why?
|
Atrial Fibrillation | 2 | 2018 | 5126 | 0.050 |
Why?
|
Lectins | 1 | 2003 | 491 | 0.050 |
Why?
|
Immunohistochemistry | 3 | 2019 | 11070 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 3 | 2004 | 1929 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2015 | 3183 | 0.050 |
Why?
|
Fas Ligand Protein | 1 | 2001 | 215 | 0.040 |
Why?
|
Interferon-alpha | 1 | 2005 | 920 | 0.040 |
Why?
|
Dendritic Cells | 2 | 2004 | 2725 | 0.040 |
Why?
|
Recombinant Proteins | 5 | 2003 | 6525 | 0.040 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2003 | 649 | 0.040 |
Why?
|
Liver | 2 | 1993 | 7531 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8623 | 0.040 |
Why?
|
Immunomagnetic Separation | 1 | 2000 | 79 | 0.040 |
Why?
|
Transplantation, Homologous | 1 | 2008 | 4808 | 0.040 |
Why?
|
G1 Phase | 2 | 2000 | 403 | 0.040 |
Why?
|
Leukocytes | 1 | 2008 | 2024 | 0.040 |
Why?
|
Phospholipase C gamma | 1 | 2020 | 130 | 0.040 |
Why?
|
DNA Damage | 2 | 2018 | 2441 | 0.040 |
Why?
|
src-Family Kinases | 1 | 2022 | 535 | 0.040 |
Why?
|
Drug Resistance, Multiple | 1 | 2000 | 257 | 0.040 |
Why?
|
Treatment Failure | 2 | 2021 | 2642 | 0.040 |
Why?
|
Genetic Association Studies | 2 | 2019 | 2723 | 0.040 |
Why?
|
Genome, Human | 1 | 2012 | 4423 | 0.040 |
Why?
|
Endothelial Growth Factors | 1 | 2001 | 673 | 0.040 |
Why?
|
Kidney | 1 | 2014 | 7046 | 0.040 |
Why?
|
Multienzyme Complexes | 1 | 2002 | 665 | 0.040 |
Why?
|
Biomarkers, Pharmacological | 2 | 2010 | 162 | 0.040 |
Why?
|
Propidium | 1 | 1998 | 42 | 0.040 |
Why?
|
Germinal Center | 1 | 2021 | 380 | 0.040 |
Why?
|
Lymphocyte Activation | 3 | 2005 | 5491 | 0.040 |
Why?
|
Toremifene | 1 | 1998 | 24 | 0.040 |
Why?
|
Pain | 1 | 2014 | 5075 | 0.040 |
Why?
|
Lymphokines | 1 | 2001 | 927 | 0.040 |
Why?
|
Indoles | 1 | 2007 | 1833 | 0.040 |
Why?
|
Viral Core Proteins | 1 | 1999 | 161 | 0.040 |
Why?
|
Clone Cells | 2 | 2016 | 1660 | 0.040 |
Why?
|
Pneumocystis carinii | 1 | 2018 | 72 | 0.040 |
Why?
|
Retina | 1 | 2009 | 2652 | 0.040 |
Why?
|
Clinical Protocols | 1 | 2004 | 1438 | 0.040 |
Why?
|
Rad51 Recombinase | 1 | 2018 | 189 | 0.040 |
Why?
|
Interleukin-2 | 1 | 2005 | 1891 | 0.040 |
Why?
|
Massachusetts | 1 | 2011 | 8826 | 0.040 |
Why?
|
RNA, Neoplasm | 2 | 2016 | 749 | 0.040 |
Why?
|
Leukemia, Plasma Cell | 1 | 1997 | 46 | 0.040 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2001 | 677 | 0.040 |
Why?
|
Transcription, Genetic | 3 | 2007 | 7597 | 0.040 |
Why?
|
Hemodynamics | 1 | 2008 | 4167 | 0.040 |
Why?
|
Phosphorylcholine | 2 | 2008 | 153 | 0.040 |
Why?
|
Ikaros Transcription Factor | 1 | 2018 | 232 | 0.040 |
Why?
|
Myeloma Proteins | 1 | 2017 | 71 | 0.040 |
Why?
|
Drug Discovery | 2 | 2016 | 1054 | 0.040 |
Why?
|
Immunologic Memory | 1 | 2004 | 1359 | 0.040 |
Why?
|
Risk Assessment | 4 | 2024 | 23953 | 0.030 |
Why?
|
Pneumonia | 1 | 2008 | 2140 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 1999 | 628 | 0.030 |
Why?
|
Plasmacytoma | 2 | 2011 | 171 | 0.030 |
Why?
|
Graft Survival | 1 | 2007 | 3806 | 0.030 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2000 | 242 | 0.030 |
Why?
|
Autoantigens | 1 | 2000 | 876 | 0.030 |
Why?
|
World Health Organization | 1 | 2022 | 1315 | 0.030 |
Why?
|
Young Adult | 2 | 2014 | 59068 | 0.030 |
Why?
|
RNA Interference | 2 | 2016 | 2832 | 0.030 |
Why?
|
Peptide Fragments | 2 | 2016 | 5105 | 0.030 |
Why?
|
London | 1 | 2016 | 234 | 0.030 |
Why?
|
Lung | 1 | 2014 | 9973 | 0.030 |
Why?
|
Coloring Agents | 1 | 1998 | 559 | 0.030 |
Why?
|
Genes, Reporter | 2 | 2016 | 1528 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2017 | 3512 | 0.030 |
Why?
|
Cell Nucleus | 2 | 2002 | 2906 | 0.030 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 1997 | 306 | 0.030 |
Why?
|
Integrin alpha4beta1 | 1 | 2015 | 119 | 0.030 |
Why?
|
Growth Substances | 1 | 1998 | 768 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2000 | 1626 | 0.030 |
Why?
|
Tumor Microenvironment | 2 | 2022 | 3874 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 3 | 2004 | 1351 | 0.030 |
Why?
|
Bence Jones Protein | 2 | 2006 | 18 | 0.030 |
Why?
|
Cell Culture Techniques | 2 | 2000 | 1667 | 0.030 |
Why?
|
Central Nervous System | 1 | 2022 | 1337 | 0.030 |
Why?
|
History, 20th Century | 1 | 2003 | 2770 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 3 | 2004 | 476 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2016 | 545 | 0.030 |
Why?
|
Serologic Tests | 1 | 2017 | 384 | 0.030 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2006 | 1640 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 3 | 2010 | 1841 | 0.030 |
Why?
|
DNA, Neoplasm | 2 | 2016 | 1745 | 0.030 |
Why?
|
Bone Marrow Diseases | 1 | 1996 | 232 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 1997 | 653 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2016 | 675 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2004 | 1807 | 0.030 |
Why?
|
Epitopes | 1 | 2000 | 2504 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2024 | 2248 | 0.030 |
Why?
|
Tamoxifen | 1 | 1998 | 964 | 0.030 |
Why?
|
Exosomes | 1 | 2018 | 424 | 0.030 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2016 | 452 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 1054 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2018 | 612 | 0.030 |
Why?
|
Lactams, Macrocyclic | 2 | 2007 | 318 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2217 | 0.030 |
Why?
|
Reference Values | 1 | 2000 | 4921 | 0.030 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 691 | 0.030 |
Why?
|
Electrophoresis | 1 | 2013 | 234 | 0.030 |
Why?
|
Monokines | 1 | 1992 | 71 | 0.030 |
Why?
|
Standard of Care | 1 | 2017 | 550 | 0.030 |
Why?
|
Nephelometry and Turbidimetry | 1 | 2012 | 91 | 0.030 |
Why?
|
Hodgkin Disease | 1 | 2000 | 1378 | 0.030 |
Why?
|
Densitometry | 1 | 2012 | 151 | 0.030 |
Why?
|
Bone Marrow Examination | 1 | 2012 | 154 | 0.030 |
Why?
|
Salmonella | 1 | 1993 | 126 | 0.030 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2007 | 425 | 0.030 |
Why?
|
Immunoglobulin Variable Region | 2 | 2004 | 419 | 0.030 |
Why?
|
Salivary Glands | 1 | 2013 | 229 | 0.030 |
Why?
|
ras Proteins | 1 | 1997 | 1052 | 0.020 |
Why?
|
Mice, Inbred BALB C | 2 | 2018 | 6206 | 0.020 |
Why?
|
Neoplasm Invasiveness | 2 | 2014 | 3587 | 0.020 |
Why?
|
T-Lymphocytes | 3 | 2024 | 10188 | 0.020 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 3 | 1999 | 441 | 0.020 |
Why?
|
Morpholines | 1 | 2015 | 580 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2014 | 515 | 0.020 |
Why?
|
Age of Onset | 1 | 2018 | 3302 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2017 | 1784 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 2 | 2007 | 3396 | 0.020 |
Why?
|
Estradiol | 1 | 1998 | 1935 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2014 | 855 | 0.020 |
Why?
|
Fibrosarcoma | 1 | 1993 | 308 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3075 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2023 | 3066 | 0.020 |
Why?
|
Protein Kinases | 1 | 1997 | 1607 | 0.020 |
Why?
|
Osteolysis | 1 | 2012 | 275 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 1998 | 2204 | 0.020 |
Why?
|
Drug Monitoring | 1 | 1996 | 961 | 0.020 |
Why?
|
Focal Adhesion Kinase 2 | 2 | 2000 | 87 | 0.020 |
Why?
|
Peptides | 1 | 2002 | 4338 | 0.020 |
Why?
|
Receptors, Interleukin-17 | 1 | 2010 | 80 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2014 | 870 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2004 | 472 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2003 | 1745 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2014 | 1062 | 0.020 |
Why?
|
Gene Silencing | 1 | 2016 | 1509 | 0.020 |
Why?
|
STAT2 Transcription Factor | 2 | 2000 | 27 | 0.020 |
Why?
|
Iodine Radioisotopes | 1 | 1993 | 1033 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1886 | 0.020 |
Why?
|
Cytokine Receptor gp130 | 2 | 2000 | 66 | 0.020 |
Why?
|
RNA, Messenger | 3 | 2016 | 12785 | 0.020 |
Why?
|
Plasmids | 1 | 2014 | 2274 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2011 | 1060 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2015 | 1119 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2002 | 4936 | 0.020 |
Why?
|
Janus Kinase 1 | 2 | 2000 | 107 | 0.020 |
Why?
|
Validation Studies as Topic | 1 | 2009 | 162 | 0.020 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1997 | 1549 | 0.020 |
Why?
|
Hematopoietic System | 1 | 2008 | 110 | 0.020 |
Why?
|
Osteoclasts | 1 | 2012 | 711 | 0.020 |
Why?
|
Biological Transport | 1 | 1993 | 2090 | 0.020 |
Why?
|
DNA, Viral | 3 | 2000 | 2201 | 0.020 |
Why?
|
Chemokines | 1 | 2012 | 960 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 4 | 2016 | 20551 | 0.020 |
Why?
|
International Agencies | 1 | 2008 | 243 | 0.020 |
Why?
|
STAT1 Transcription Factor | 2 | 2000 | 340 | 0.020 |
Why?
|
3T3 Cells | 2 | 2000 | 1084 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2021 | 12320 | 0.020 |
Why?
|
Ubiquitination | 1 | 2012 | 1006 | 0.020 |
Why?
|
Binding Sites | 1 | 2016 | 6042 | 0.020 |
Why?
|
Receptors, Laminin | 1 | 2006 | 26 | 0.020 |
Why?
|
Population Surveillance | 1 | 2017 | 2603 | 0.020 |
Why?
|
Bone Transplantation | 2 | 2005 | 926 | 0.020 |
Why?
|
Benzoquinones | 1 | 2007 | 198 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2007 | 384 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2022 | 14397 | 0.020 |
Why?
|
Histones | 1 | 2016 | 2577 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9326 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2007 | 465 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2014 | 1347 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5427 | 0.020 |
Why?
|
Introns | 1 | 2008 | 981 | 0.020 |
Why?
|
Lactones | 1 | 2008 | 317 | 0.020 |
Why?
|
Janus Kinase 2 | 2 | 2000 | 544 | 0.020 |
Why?
|
Ligands | 2 | 2002 | 3270 | 0.020 |
Why?
|
Stimulation, Chemical | 1 | 2005 | 306 | 0.020 |
Why?
|
Drug Interactions | 2 | 2001 | 1415 | 0.020 |
Why?
|
Th1 Cells | 1 | 2010 | 1037 | 0.020 |
Why?
|
Family | 1 | 2016 | 3189 | 0.020 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2005 | 321 | 0.010 |
Why?
|
Oligonucleotides, Antisense | 2 | 1997 | 461 | 0.010 |
Why?
|
Tea | 1 | 2006 | 287 | 0.010 |
Why?
|
Education, Medical, Continuing | 1 | 2010 | 824 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2000 | 14661 | 0.010 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2005 | 293 | 0.010 |
Why?
|
Monocytes | 1 | 1994 | 2572 | 0.010 |
Why?
|
Syndecans | 1 | 2004 | 75 | 0.010 |
Why?
|
Phytotherapy | 1 | 2006 | 296 | 0.010 |
Why?
|
Heterozygote | 1 | 2011 | 2798 | 0.010 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2004 | 516 | 0.010 |
Why?
|
RNA Splicing | 1 | 2008 | 915 | 0.010 |
Why?
|
Cell Fusion | 1 | 2004 | 294 | 0.010 |
Why?
|
Forecasting | 1 | 2012 | 2925 | 0.010 |
Why?
|
I-kappa B Proteins | 1 | 2004 | 211 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2005 | 868 | 0.010 |
Why?
|
Receptors, Interleukin-2 | 1 | 2005 | 562 | 0.010 |
Why?
|
Transcription Factor AP-1 | 1 | 2005 | 321 | 0.010 |
Why?
|
Syndecan-1 | 1 | 2004 | 163 | 0.010 |
Why?
|
Hematopoiesis | 1 | 2012 | 2049 | 0.010 |
Why?
|
Physician's Role | 1 | 2010 | 916 | 0.010 |
Why?
|
Pedigree | 1 | 2011 | 4586 | 0.010 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2003 | 283 | 0.010 |
Why?
|
NFATC Transcription Factors | 1 | 2005 | 389 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15257 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10494 | 0.010 |
Why?
|
Exons | 1 | 2008 | 2392 | 0.010 |
Why?
|
Cytochrome c Group | 1 | 2002 | 121 | 0.010 |
Why?
|
Administration, Oral | 1 | 2010 | 4010 | 0.010 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2002 | 325 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1993 | 8163 | 0.010 |
Why?
|
Pyrroles | 1 | 2008 | 1126 | 0.010 |
Why?
|
Cell Separation | 1 | 2007 | 1720 | 0.010 |
Why?
|
Protein Array Analysis | 1 | 2003 | 400 | 0.010 |
Why?
|
SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 2000 | 43 | 0.010 |
Why?
|
Fluorescence | 1 | 2003 | 756 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2003 | 836 | 0.010 |
Why?
|
Proteoglycans | 1 | 2004 | 803 | 0.010 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2000 | 120 | 0.010 |
Why?
|
DNA-Activated Protein Kinase | 1 | 2000 | 112 | 0.010 |
Why?
|
Cell-Free System | 1 | 2000 | 340 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2001 | 748 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 2003 | 1122 | 0.010 |
Why?
|
Cysteine Endopeptidases | 1 | 2002 | 548 | 0.010 |
Why?
|
src Homology Domains | 1 | 2000 | 361 | 0.010 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2000 | 223 | 0.010 |
Why?
|
Sequence Analysis, Protein | 1 | 2000 | 258 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2006 | 1474 | 0.010 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2001 | 591 | 0.010 |
Why?
|
International Cooperation | 1 | 2006 | 1428 | 0.010 |
Why?
|
Jurkat Cells | 1 | 2000 | 739 | 0.010 |
Why?
|
Cyclin D | 1 | 1999 | 72 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 2001 | 778 | 0.010 |
Why?
|
Melphalan | 1 | 2000 | 420 | 0.010 |
Why?
|
Hybridomas | 1 | 2000 | 442 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2001 | 584 | 0.010 |
Why?
|
Radiation, Ionizing | 1 | 1999 | 251 | 0.010 |
Why?
|
Heat-Shock Proteins | 1 | 2002 | 795 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2004 | 1254 | 0.010 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2000 | 331 | 0.010 |
Why?
|
Catalytic Domain | 1 | 2000 | 705 | 0.010 |
Why?
|
Antigens | 1 | 2004 | 1446 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 2004 | 1559 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2003 | 2060 | 0.010 |
Why?
|
Cell Lineage | 1 | 2007 | 2539 | 0.010 |
Why?
|
Shc Signaling Adaptor Proteins | 1 | 1997 | 46 | 0.010 |
Why?
|
Cyclin D2 | 1 | 1997 | 98 | 0.010 |
Why?
|
Gamma Rays | 1 | 1999 | 318 | 0.010 |
Why?
|
TYK2 Kinase | 1 | 1997 | 38 | 0.010 |
Why?
|
SOS1 Protein | 1 | 1997 | 40 | 0.010 |
Why?
|
Ubiquitin | 1 | 2002 | 838 | 0.010 |
Why?
|
ras Guanine Nucleotide Exchange Factors | 1 | 1997 | 34 | 0.010 |
Why?
|
Antibodies, Blocking | 1 | 1998 | 243 | 0.010 |
Why?
|
Genes, p53 | 1 | 2000 | 712 | 0.010 |
Why?
|
GRB2 Adaptor Protein | 1 | 1997 | 101 | 0.010 |
Why?
|
Aging | 1 | 1996 | 8689 | 0.010 |
Why?
|
Precipitin Tests | 1 | 1998 | 815 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 1999 | 631 | 0.010 |
Why?
|
Antibodies, Heterophile | 1 | 1997 | 128 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2000 | 641 | 0.010 |
Why?
|
Fetal Tissue Transplantation | 1 | 1997 | 137 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2004 | 2647 | 0.010 |
Why?
|
Flavonoids | 1 | 2000 | 444 | 0.010 |
Why?
|
Rats | 1 | 1993 | 23712 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2008 | 2224 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1997 | 359 | 0.010 |
Why?
|
Child | 2 | 1996 | 80086 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6475 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2002 | 1314 | 0.010 |
Why?
|
Imidazoles | 1 | 2002 | 1179 | 0.010 |
Why?
|
Acute Disease | 1 | 2006 | 7230 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2003 | 2189 | 0.010 |
Why?
|
Thiazoles | 1 | 2003 | 1513 | 0.010 |
Why?
|
Tyrosine | 1 | 2000 | 1438 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 1997 | 367 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2002 | 1611 | 0.010 |
Why?
|
Fibronectins | 1 | 1998 | 723 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 1997 | 556 | 0.010 |
Why?
|
DNA Replication | 1 | 2000 | 1418 | 0.010 |
Why?
|
Cell Count | 1 | 1997 | 1834 | 0.010 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 1997 | 569 | 0.010 |
Why?
|
Cytoplasm | 1 | 1998 | 1511 | 0.010 |
Why?
|
Fungal Proteins | 1 | 1997 | 910 | 0.010 |
Why?
|
Cost of Illness | 1 | 2003 | 1931 | 0.010 |
Why?
|
Temperature | 1 | 2000 | 2228 | 0.010 |
Why?
|
Kinetics | 1 | 2000 | 6377 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 1997 | 1205 | 0.010 |
Why?
|
Proteins | 2 | 1997 | 6033 | 0.010 |
Why?
|
Antibodies | 1 | 2000 | 2421 | 0.010 |
Why?
|
Weight Loss | 1 | 2003 | 2683 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2001 | 3486 | 0.010 |
Why?
|
DNA | 1 | 2004 | 7208 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2007 | 20078 | 0.000 |
Why?
|
Cell Membrane | 1 | 1998 | 3685 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2006 | 15820 | 0.000 |
Why?
|
Neoplasm Metastasis | 1 | 1997 | 4903 | 0.000 |
Why?
|
Repressor Proteins | 1 | 1997 | 2978 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 2003 | 7424 | 0.000 |
Why?
|